57.90EUR-1.19%Mkt Cap: 3.22B $P/E: 22.441d ago
Laboratorios Farmaceuticos Rovi, S.A. manufactures, sells, and markets pharmaceutical products in Spain, European Union, OECD countries, and internationally. The company offers prescription products, including Ameride, B…
Industry Peers
Drug Manufacturers - Specialty & Genericvs Drug Manufacturers - Specialty & Generic
P/E
Avg
P/B
Pricier
Div Yield
Avg
1M Perf
Avg
Indicators:|
Key Statistics
Company
Market Cap3.22B $
Enterprise Value3.25B $
Revenue (TTM)805.53M $
Gross Profit524.66M $
Net Income (TTM)152.65M $
Revenue/Share15.75 USD
Last Price57.90 EUR
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees1.9K
CountryES
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISINES0157261019
Valuation
P/E (Trailing)22.44
P/E (Forward)16.67
PEG1.26
EV/EBITDA16.29
EV/Revenue4.03
P/S3.99
P/B4.39
EPS (TTM)2.58
EPS (Forward)3.47
52W Range
51.6518% of range86.70
52W High86.70 EUR
52W Low51.65 EUR
Profitability
Gross Margin64.92%
Oper. Margin6.48%
EBITDA Margin24.75%
Profit Margin18.89%
ROE21.14%
ROA14.70%
Growth
Revenue Growth-1.50%
Earnings Growth—
Cash Flow & Leverage
Operating CF203.35M $
CapEx (TTM)73.71M $
FCF Margin10.21%
FCF Yield2.56%
Net Debt18.53M $
Net Debt/EBITDA0.09
Balance Sheet
Debt/Equity0.18
Current Ratio3.65
Quick Ratio1.77
Book Value/Sh13.18 EUR
Cash/Share1.904 EUR
Dividends
Fwd Div Rate0.9600 EUR
Trail. Div Rate0.0000 EUR
Div. Yield1.63%
5Y Avg Yield1.61%
Payout Ratio36.22%
Ex-Div DateJul 13, 2026
Pay Date—
Analyst Consensus
Rating—
Target (Mean)75.38 EUR
Upside (mean)+30.2%
Target Range64.20 EUR – 84.00 EUR
€64.20+30.2% to mean€84.00
# Analysts9
Ownership
Shares Out.51.15M
Float16.21M
Insiders68.20%
Institutions19.38%
Technical
SMA 5064.25 (-9.9%)
SMA 20067.48 (-14.2%)
Beta0.22
S&P 52W Chg20.05%
Avg Vol (30d)97.36K
Avg Vol (10d)110.64K
Technical Indicators
RSI (14)34.6
MACD-1.3317
MACD Signal-1.8401
MACD Hist.+0.5084
BB Upper59.61 EUR
BB Middle58.54 EUR
BB Lower57.46 EUR
BB Width3.67%
ATR (14)1.321 EUR
Vol Ratio (20d)0.86x